The Relationship of Lipoprotein (a) (Lp(a)) to Risk Factors of Coronary Heart Disease: Initial results of the prospective epidemiological study on Company employees in Westfalia by Schriewer, H. et al.
Schriewer, Assmann, Sandkamp and Schulte: Lp(a) and risk factors of coronary heart disease 591
J. Clin. Chem. Clin. Biochem.
Vol. 22, 1984, pp. 591-596
The Relationship of Lipoprotein (a) (Lp(a)) to Risk Factors
of Coronary Heart Disease:
Initial results of the prospective epidemiological study on Company employees in Westfalia
By H. Schriewer, G. Assmann, M. Sandkamp
Institut für Klinische Chemie und Laboratoriumsmedizin (Zentrallaboratorium),
Medizinische Einrichtungen der Westfälischen Wilhelms-Universität, Münster and
H. Schulte
Institut für Arterioskleroseforschung, Westfälische Wilhelms-Universität, Münster
(Received March 12/June 5, 1984)
Summary: Lp (a) concentrations were determined in 987 male and 477 female Company employees in Westfa-
lia, in the age ränge 17—70 years. These values were then related to age and to the following risk factors:
obesity, smoking, hypertension, hypertriglyceridaemia, hypercholesterolaemia, hyperbetalipoproteinaemia,
hypoalphalipöproteinaemia, hyperglycaemia and hyperuricaemia.
The Lp(a) values showed a similar markedly skewed distribution for both men and women. The median for
men was 0.039 g/l, for women 0.050 g/l. In both sexes only about 25% of all Lp(a) values were above 0.10
g/l. Raised Lp(a) values (>0.30 g/l) were föund in 6.5% of males and in 6.1% of females.
A significantly higher frequency of raised Lp(a) values (>0.30 g/l) was found in: post-menopausal women
(11.3% äs against 4.1%, p < 0.01); females with hypercholesterolaemia (19.0% when cholesterol values
were ^6.73 mmol/1, 10.8 % when cholesterol values were between 5.70—6.72 mmöl/1, 3.0% when choleste-
rol values were <5.70 mmol/1, p < 0.001); and females with hyperbetalipoproteinaemia (22.6% when LDL
cholesterol values were 5*4.92 mmol/1, 5.0% when LDL cholesterol values were <4.92 mmol/1, p < 0.001).
12.0% of men with hypoalphalipoproteinaemia (HDL cholesterol values <0.907 mmol/1) had Lp(a) values
>0.30 g/l, äs against 5.5% of men with HDL cholesterol values ^0.907 mmol/1 (p < 0.01).
This percentage rate increased to 16.9% when hypertriglyceridaernia (^2.28 mmol/1 triglycerides) was also
present. All other risk factors which were examined and their combinations had no significant influence on the
prevalence of raised Lp (a) .concentrations.
Beziehung von Lipoprotein (a) (Lp (a)) zu Risikofaktoren der koronaren Herzkrankheit:
Erste Ergebnisse der prospektiven epidemiologischen Studie bei Betriebsangehörigen in Westfalen
Zusammenfassung: Bei 987 männlichen und 477 weiblichen Betriebsangehörigen in Westfalen im Alter von
17—70 Jahren wurden die Lp(a)-Konzentrationen im Serum bestimmt und zum Alter und zu folgenden
Risikofaktoren in Beziehung gesetzt: Übergewicht, Rauchen, Hypertonie, Hypertriglyceridämie, Hypercho-
lesterinämie, Hyperbetalipoproteinämie, Hypoalphalipoproteinämie, Hyperglykämie und Hyperurikämie.
Die Lp (a) Werte wiesen bei beiden Geschlechtern annähernd die gleiche auffällig schiefe Verteilung auf. Der
Median betrug bei Männern 0,039 g/l, bei Frauen 0,050 g/1. Bei beiden Geschlechtern lagen nur etwa 25%
aller Lp(a)-Werte über 0,10 g/l. Erhöhte Lp(a)-Werte (>0,30 g/l) wiesen 6,5% der Männer und 6,1% der
Frauen auf.
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Signifikant größere relative Häufigkeiten von erhöhten Lp(a)-Konzentrationen (>0,30 g/l) traten auf: bei
Frauen nach Eintritt der Menopause (11,3% gegenüber 4,1%, p < 0,01), bei weiblichen Probanden mit
Hypercholesterinämie (19,0% bei Cholesterinwerten ^6,73 mmol/1, 10,8% bei Cholesterinwerten von
5,70-6,72 mmol/1, 3,0% bei Cholesterinwerten <5,70 mmol/1, p < 0,001), und mit Hyperbetalipoproteinä-
mie (22,6% bei LDL-Cholesterinwerten ^4,92 mmol/1, 5,0% bei LDL-Cholesterinwerten <4,92 mmol/1, p
< 0,001). - " ·
Bei Männern mit Hypoalphalipoproteinämie (HDL-Cholesterinwerte <0,907 mmol/1) traten in 12,0%
Lp(a)-Werte größer als 0,30 g/1 auf, gegenüber 5,5% bei Probanden mit HDL-Cholesterinwerteii ^0,907
mmol/1, < 0,01). Dieser Prozentsatz stieg auf 16,9% an, falls gleichzeitig eine Hypertriglyceridämie vorlag
(Triglyceride 5*2,28 mmol/1). Alle anderen untersuchten Risikofaktoren und deren Kombinationen hatten
keinen signifikanten Einfluß auf die Prävalenz erhöhter Lp(a)-Konzentrationen.
Introduction
Lipoprotein (a) (Lp (a)) is a cholesterol-rich lipopro-
tein in blood serum with electrophoretic pre-ß-mo-
bility (1) and a lipid composition similar to low den-
sity lipoproteins (LDL) (2). Like LDL, Lp (a) con-
tains mainly apolipoprotein B (62%), but also Lp (a)
apolipoprotein (20%) and albumin (15%) (3). Un-
like LDL, Lp(a) floats in a higher density ränge
(1.055—1.110 kg/l) (4) and has a higher proportion
of carbohydrate (3). Lp (a) is present in almost all
individuals, although the concentrations can vary
quite considerably (5).
Various projects agree in their findings that individu-
als with raised Lp(a) values run a higher risk of de-
veloping coronary heart disease prematurely (6—8).
Lp (a) does not correlate significantly with other risk
factors such äs age, sex, cholesterol, triglycerides (l,
8, 9) or cigarette smoking (10). Results of epidemio-
logical studies on the correlation of Lp(a) values and
premature development of coronary heart disease
have not been available until now.
This present study reports the first results of our
epidemiological study on the distribution of Lp (a)
values in Company employees in Westfalia, and the
correlation of Lp (a) values to risk factors for coro-
nary heart disease in these subjects.
Lipoprotein (a) assay
For the determination of lipoprotein (a) (Lp(a)) in blood serum,
one dimensional Laurell immunelectrophoresis was used (12). As
antibody we used Antihuman Lp(a) from sheep (Immuno Comp.,
D-6900 Heidelberg, order no. 4845005).
As Standard reference Human Lp(a) (Immuno Comp. D^6900
Heidelberg, order no. 4395005) was used.
Analysis of HDL components
HD L cholesterol was enzymatically analysed using the CHOD-
PAP method (Boehringer Mannheim, test cornbination no.
187313), äs described elsewhere (13). Determination of HDL
phosphatidyl choline was carried out äs enzymatic colour test
using the centrifugal analyser Cobas Bio (Hoffmann La Röche).
This method is described in detail elsewhere (14).
Analysis of LDL components
LDL cholesterol and LDL apolipoprotein B were determined fol-
lowing selective precipitation pf, VLDL with phosphotungstic
acid/MgCb äs described in detail elsewhere
Statisücs
Comparisons of frequencies were done by the x2-test. To test
whether two distributions are equal, we used the Mann-Whitney
IMest, and for multiple comparisons the test by Nemenyi. We
calculated with Kendall's instead of Spearman's rank correlation
coefficients because of the high number of tied ranks.
The significance level was set at 0.05.
Materials and Methods
Sample material
As test material we used fresh serum from the test series "Pros-
pective epidemiological study of Company employees in Westfa-
lia" (11).
Methods
Analyses of cholesterol, triglycerides, glucojse and uric acid were
performed with the SMAC Analyser (Technicon GmbH, Bad Vü-
bel, FRG) äs described elsewhere (11).
Results
Description of the test group
Lp(a) concentrations in serurn were determined in
987 male and 477 female Company employees in
Westfalia. The average age of the men was 42.1
years (± 10.8 years), of the wome» 36,4 years (i
13.2 years), age ränge: 17 to 70 years. The medium
Broca index for men was 104.0% ± 13.3%, with a
•ränge of 72% to 161%, for women 99.0% ± 16.6%,
with a ränge of 69% to 165%; 30.7% of the men
were smokers with an average consümption of 18.8
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Tab. 1. Distribution parameters of measured values in men
(n = 987).






















































































Tab. 2. Distribution parameters of measured values in women
, (n - 477).









































































































cigarettes a day. Of the women, 34.8% were smok-
ers with an average consumption of 15.9 cigarettes a
day. Medium valueSj Standard deviations and Varia-
tion r nge of additional measured values and of la-
boratory parameters are given in tables l and 2.
Distribution of Lp (a) concentrations
For both sexes Lp(a) values had a similar high
skewed distribution (tab. 3). In 14% of men and
12% of women values were below 0.02 g/l; 23% of
men and 19% of women had values of 0.02 g/l, and
13% of men and 10% of women had values of 0.03
g/1. Only approx. 25% of all men and women had
values >0.10 g/l. In both sexes, the proportion of
subjects with Lp(a) concentrations of >0.25 g/l was
10%, 5% hadLp(a) concentrations >0.37 g/l. 6.5%
f men and 6.1% of women had Lp(a) values >0.30
g/i.
Correlation of Lp (a) values to age
Whereas in men a correlation to age could not be
statistically proven, there.was a pronounced positive
correlatio0 of age to Lp (a) values in women (r =
0.12, p < 0.001), with a sudden increase in values
for 40—50 year olds, i.e. approx. at the onset of the
menopause. The medium value of Lp (a) in pre-
menopausal women was 0.094 ± 0.129 g/l, in post-
menopausal women it was 0.131 ± 0.171 g/l (p <
0.001). The proportion of subjects with raised Lp(a)
values (>0.30 g/l) increased with the onset of the
menopause frofn 4.1% to 11.3% (p < 0.01).
, Tab. 3. Distribution of Lp(a) (g/l).







































J. Clin. Chem. Clin. Biochem. /Vol. 22, 1984 / No. 9
594 Schriewer, Assmann, Sandkamp and Schulte: Lp(a) and risk factors of coronary heart disease
Correlation of Lp (a) values to atherogenic risk fac-
tors (tab. 4)
In both sexes there was a positive correlation of
Lp(a) concentrations to cholesterol, which was,
however, more pronounced in women than in men
(men: r = 0.05, p < 0.05; women: r = 0.13, p <
0.01); and also to LDL cholesterol (men: r = 0.07, p
< 0.01; women: r = 0.15, p < 0.001), whereas only
women showed a correlation of Lp (a) values and net
cholesterol (= total cholesterol - Lp (a) cholesterol)
(r = 0.07, p < 0.05). No significant correlation could
be shown in either sex for Lp (a) to LDL apolipopro-
tein B.
Tab. 4. Coefficients of correlations between Lp(a) and risk fac-
tors.
Prospective epidemiological study of Company employees
in Westfalia.
987 men, 477 women.
* = p \< 0.05
** = p < 0.01
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0.09 (n = 214)
0.02 (n = 166)
0.07*
There was an unexpected positive correlation in men
of Lp(a) to HDL cholesterol (r = 0.06, p < 0.01)
and a negative correlation to relative body weight
(Brocd) (r = -0.05, p < 0.05). Furthermore, in
women, a positive correlation was observed of Lp(a)
values to the Broca index (r = 0.10, p < 0.01), äs
well äs Lp (a) values to systolic blood pressure (r =
0.07, p < 0.05). When the female subjects were di-
vided into pre- and post-menopausal groups, the
correlation of Lp (a) values to the systolic blood
pressure disappeared, whereas the other correlations
remained unchanged. No significant correlation of
Lp (a) values to systolic blood pressure was observed
in men. Neither sex showed statistically significant
correlations of Lp (a) values to diastoüc blood pres-
sure, glucose, uric acid, triglycerides, HDL phospha-
tidyl choline or cigarette consumption.
Taking the Lp (a) concentration äs an independent
factor, the prevalence of the tested risk factors was
cornpared in subjects with Lp(a) values >0.30 g/l
(always mentioned first) and in those with Lp (a)
values < = 0.30 g/l; the following results were ob-
tained: The proportion of men vSith hypoalphalipo-
proteinaemia was significantly raised (p < 0.01)
(28.1% äs opposed to 14.3%; 15.6% äs opposed to
5.3% when combined with hypertriglyceridaemia).
In women the proportion of subjects with hypercho-
lesterolaemia was 27.6% in the group with Lp(a)
values >0.30 g/l, whereas only 7.6% of the remain-
ing subjects showed hypercholesterolaemia. The cor-
responding values for hyperbetalipoproteinaemia
were 24.1% compared to 5.5%. In both cases the
proportion of affected subjects is significantly in-
creased (p < 0.001). The proportion of female sub-
jects showing Lp(a) values >0.30 g/l after the onset
of the menopause was also significantly increased
(51.7% compared to 26.3%; p < 0.01). Further re-
markable but not significant differences were ob-
served in men:
Hypercholesterolaemia 20.3% compared to 12.3%,
Hypertriglyceridaemia 25.0% compared to 16.8%,
Hyperbetalipoproteinaemia 15.6% compared to
8.9%.
Lp (a) values in hyperlipidaemic employees
The proportion of female subjects with raised Lp(a)
values (>0.30 g/l) increased clearly with increasirig
cholesterol values (<5.70 mmol/1: 3.0%; 5.70-6.72
mmol/1: 10.8%; 2*6.73 mmol/1: 19.0%, p < 0.001),
äs well äs with increasing LDL cholesterol values
(LDL cholesterol <4.92 mmol/I: 5.0%; LDL cho-
lesterol ^4.92 mmol/1: 22.6%; p < 0.001). In men,
the relative frequency of higher Lp (a) values was,
however, not dependent on total cholesterol of LDL
cholesterol levels (cholesterol <5.70 mmol/1: 5.5%;
5.70-6.72 mmol/1: 6.9%; ^6.73 mmol/1: 10.3%
(not significant); LDL cholesterol <4.92. mmol/1:
6.3%; 2*4.92 mmol/1: 11.2% (not significant)).
9.4% of the hypertriglyceridaemic men (triglyce-
rides ^2.28 mmol/1) had raised Lp (a) values (>0.30
g/l), and this proportion was marginally but not sig^
nificantly higher than that in the remairiing test
group (5.9%).
In hypertriglyceridaeinics with HDL cholesterol
values <0.907 mmol/1, the prevalence of high Lp(a)
values (>0.3 g/l) was higher thfan in the remaining
test group (16.9% compared with 5.8%) (p < 0.01).
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A general increase of Lp (a) values was, however,
not observed in these individuals (median 0.02 g/1).
Corresponding calculations for women were not
feasible due to the low prevalence of hypertriglyceri-
daemia.
Discussion
An essential characteristic of Lp (a) lipoprotein is its
markedly skewed distribution in the population. This
has been shown by several authors (l, 5, 8, 16—18)
and confirmed by us. The majority of the population
obviously has relatively low Lp(a) concentrations,
and higher Lp(a) values are found in only a few indi-
viduals. Individuais with Lp(a) values >0.30 g/l
show corresponding "sinking pre-beta bands" in
electrophoresis (19). It has been shown that the
sinking pre-beta bands are passed on by autosomal
dominant inheritance (19—21). In our tests, the me-
dian value for Lp(a) was about 0.04 g/ for men and
0.05 g/l for women; the 90th percentile was at 0.25
g/l (men) and 0.24 g/l (women); and the 95th per-
centile at 0.37 g/l (men), 0.35 g/l (women). These
values are lower than those found by Albers et al.
(1): median: 0.08 g/l, 90th percentile: 0.39 g/l, 95th
percentile: 0.51 g/l; and by Kostner et al. (8): 80th
percentile: 0.26 g/l, 90% percentile: 0.50 g/l. In the
work of Walton et al. (16), however, the 95th per-
centile for a normal population was 0.20 g/l. The
reason for this discrepancy in the frequency distribu-
tion of high Lp(a) values can on the one hand be due
to the application of different Standards in the Lp (a)
analysis, on the other hand it could be due to real
differences in the tested population.
Various research projects agree in their finding that
patients with coronary heart disease have obviously
higher Lp(a) Values than healthy controls (6—8).
Kostner et al. established a cut-off point at 0.3 g/l,
above whieh an increased risk of coronary heart dis-
ease can be assumed (8). It has also been shown re-
peatedly, that Lp(a) has no bearing on known coro-
nary risk factors, such äs age, chplesterol, triglyce-
rides (l, 8, 9) or cigarette consumption (10). How-
ever, the correlation of Lp (a) value and risk factors
has so far only been tested on a relatively small scale
in predominantly clinical orientated research, and to
our knowledge, there are äs yet no prospective
epidemiological studies with larger numbers of sub-
jects. Contrary to data published so far, we found a
pronounced positive correlation of age to Lp (a)
values in women. The division of the subjects into
age groups showed, however, that the correlation re-
sults from a sharp increase in Lp(a) in 40—50 year
old women, and is hence possibly related to the onset
of the menopause. Since in >40—50 year old women
LDL cholesterol values are also enhanced (22) and
since in our results Lp (a) values are positively corre-
lated with total cholesterol levels äs well äs with
LDL cholesterol values one might speculate that the
increase in Lp (a) values in post-menopausal women
may be related to a common catabolic pathway of
LDL and Lp (a). Based on the observation that the
hepatic B, E receptor can be stimulated by pharma-
cological doses of oestrogen (23), changes in the
plasma levels of LDL in postmenopausal women
may be caused by reciprocal changes in the activity
of the hepatic B, E receptor. At present, however,
there are contradictory results with regard to the role
of B, E receptörs in the metabolism of Lp(a). Ac-
cording to findings of Floren et al. (24), Lp(a) was
taken up mainly by the LDL receptor pathway, while
according to the results of Martmann-Moe & Berg
(25), Lp(a) was taken up independently of the LDL
receptor pathway. Another indication for a different
catabolic pathway of LDL and Lp (a) is the observa-
tion that in hypercholesterolaemic patients the appli-
cation of cholestyramine only resulted in a reduction
of the plasma LDL level without any change of the
Lp(a) level (26).
Research by Walton et al. (16) or Kostner et al. (8)
shows that individuals with hyperlipidaemia fre-
quently have higher Lp (a) values than normolipi-
daemics. These observations were confirmed in our
research: in subjects with hypertriglyceridaemia and
hypoalphalipoproteinaemia there was a relatively
higher proportion of subjects with Lp (a) values
>0.30 g/l cornpared to normolipidaemics.
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